UDIBI

Development and validation of a mass spectrometric method to determine the identity of rituximab based on its microheterogeneity profile....

Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy. VER MÁS

Fecha de publicación: 20 de marzo del 2021 Consistency of a dialyzable leucocyte extract manufactured at GMPfacilities by Nuclear...

Transcriptome-based identification of lovastatin as a breast cancer stem cell-targeting drug. VER MÁS

Fecha de publicación: 6 de septiembre de 2022 In Vitro and In Vivo Characterization of a Broadly Neutralizing Anti-SARS-CoV-2...

Validation of a cell proliferation assay to assess the potency of a Dialyzable Leucocyte Extract intended for batch release....

An international comparative analysis and roadmap to sustainable biosimilar markets. VER MÁS

The yin/yang of inflammatory status: Blood-brain barrier regulation during sleep. VER MÁS